|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Healthy | |||||
| 2 | Interventions listed in this trial | ||||
| Rabeprazole Sodium Tablets 20 mg | |||||
| Aciphex® Tablets 20 mg | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Rabeprazole | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-Ulcer Agents | |||||
| Enzyme Inhibitors | |||||
| Gastrointestinal Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Mylan Pharmaceuticals | |||||